Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
antibody development | 1.43 | 0.8 | 5609 | 94 | 20 |
antibody | 0.3 | 0.3 | 9868 | 27 | 8 |
development | 1.07 | 0.9 | 3883 | 21 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
antibody development | 0.78 | 0.2 | 6312 | 94 |
antibody development process | 1.6 | 0.9 | 1354 | 84 |
antibody development timeline | 0.73 | 0.3 | 322 | 91 |
antibody development company | 0.02 | 0.4 | 1204 | 60 |
antibody development side effect | 1.12 | 0.5 | 20 | 56 |
antibody development ppt | 1.44 | 1 | 1262 | 9 |
antibody development service | 1.89 | 0.5 | 6207 | 74 |
antibody development for peg | 0.97 | 1 | 6710 | 85 |
antibody development review | 0.09 | 0.6 | 3340 | 78 |
antibody development overview | 1.01 | 0.2 | 150 | 68 |
antibody development workflow | 1.46 | 0.4 | 1168 | 91 |
antibody development to emgality | 1.92 | 0.3 | 6328 | 61 |
antibody development enhancement | 0.96 | 0.6 | 1200 | 94 |
antibody development timeline covid | 0.94 | 0.8 | 5815 | 49 |
monoclonal antibody development | 0.76 | 0.9 | 6342 | 41 |
development of an antibody within 2 days | 0.88 | 0.4 | 1280 | 91 |
custom antibody development | 0.57 | 0.7 | 5380 | 47 |
antibody drug conjugate development | 0.33 | 0.7 | 533 | 44 |
bispecific antibody development | 1.74 | 0.7 | 996 | 11 |
antibody drug development | 1 | 0.5 | 2138 | 11 |
bispecific antibody development programs | 0.17 | 0.6 | 1350 | 2 |
tug monoclonal antibody development | 0.15 | 0.1 | 7673 | 24 |